2026-2027 | Live Session | Vaping and Tobacco Use: Background, Epidemiology, Regulatory Issues, Safety | September 2026-Vaping and Tobacco Use: Background, Epidemiology, Regulatory Issues, Safety Presentation

Vaping and Tobacco Use: Background, Epidemiology, Regulatory Issues, Safety Presentation

Pdf Summary

This presentation reviews the history, health effects, treatment, and regulation of tobacco and vaping products. Tobacco use dates back thousands of years, and smoking remains a major preventable cause of death. Nicotine use disproportionately affects several groups facing social and economic disadvantage; initiation commonly occurs during adolescence and young adulthood.<br /><br />Vaping devices evolved from early vaporizer concepts into widely marketed electronic nicotine delivery systems. Although often perceived as harmless, their aerosols can contain carcinogens, toxic chemicals, heavy metals, and ultrafine particles. Potential harms include cardiovascular and pulmonary effects, nicotine dependence, and possible cancer risks; long-term human evidence remains limited. Youth use is a particular concern, with flavored products and high-nicotine devices contributing to appeal and exposure. Vaping cannabis is also increasing, and may cause respiratory symptoms. The presentation emphasizes that vaping is not risk-free and that using both cigarettes and e-cigarettes can preserve or compound health risks.<br /><br />Nicotine reaches the brain rapidly and alters several neurotransmitter systems. Dependence involves receptor adaptation, tolerance, and learned cues. Withdrawal can begin within one to two days of stopping and involve cravings, irritability, anxiety, low mood, and frustration. Screening tools such as the Fagerström Test and Heaviness of Smoking Index can help assess dependence and guide care.<br /><br />Recommended cessation approaches include counseling, motivational interviewing, cognitive behavioral strategies, quitlines, and medications such as nicotine replacement therapy, varenicline, and bupropion. Evidence suggests nicotine e-cigarettes may help some adults stop smoking, but uncertainty remains about long-term outcomes and vaping cessation. For adults choosing e-cigarettes, the presentation recommends using authorized products, completely replacing combustible cigarettes rather than dual-using, and arranging behavioral support and follow-up.<br /><br />FDA regulation has expanded, but enforcement gaps and product-market loopholes persist. The presenters call for stronger screening and evidence-based treatment, attention to equity, and continued evaluation of vaping’s role in harm reduction and cessation.

Keywords

tobacco use

vaping products

nicotine dependence

smoking cessation

electronic nicotine delivery systems

adolescent use

health effects

FDA regulation

harm reduction

quitlines